New York State Common Retirement Fund’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-33
Closed -$358 3313
2024
Q2
$358 Sell
33
-1,275
-97% -$17.3K ﹤0.01% 3358
2024
Q1
$19.4K Hold
1,308
﹤0.01% 3144
2023
Q4
$25K Sell
1,308
-9
-0.7% -$220 ﹤0.01% 3125
2023
Q3
$35.5K Buy
1,317
+21
+2% +$910 ﹤0.01% 3101
2023
Q2
$58.7K Hold
1,296
﹤0.01% 3101
2023
Q1
$59.2K Buy
1,296
+3
+0.2% +$155 ﹤0.01% 2949
2022
Q4
$68K Buy
1,293
+1
+0.1% +$59 ﹤0.01% 3045
2022
Q3
$150K Sell
1,292
-319
-20% -$28.4K ﹤0.01% 2880
2022
Q2
$97K Buy
1,611
+1,052
+188% +$79K ﹤0.01% 3072
2022
Q1
$31K Hold
559
﹤0.01% 3249
2021
Q4
$43K Buy
559
+9
+2% +$1.05K ﹤0.01% 3246
2021
Q3
$77K Buy
+550
New +$64.5K ﹤0.01% 3191

Other funds holding RLYB

New York State Common Retirement Fund's RLYB Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Rallybio (RLYB) in Q3 2024, closing a stake of 33 shares — an estimated $358 sold.

New York State Common Retirement Fund first reported a position in RLYB in Q3 2021 and held it in 12 quarters. The position peaked at $150K in Q3 2022. 49 funds tracked by Wall St. Rank hold RLYB as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Rallybio position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 33 Rallybio shares in Q3 2024, an estimated $358.
  • New York State Common Retirement Fund first reported a position in Rallybio in Q3 2021 and held it in 12 quarters.
  • New York State Common Retirement Fund's Rallybio position peaked at $150K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Rallybio as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.